Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
| Image |  |
|---|---|
| Description | scientific article published on 19 March 2015 |
| Author/s |
author: Elias Karl Mai |
| Publication date | March 19, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |